<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

thenextweb
Novo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed Cellular Intelligence

Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment Novo discontinued last October. Novo Nordisk has handed over STEM-PD, an experimental stem-cell therapy for Parkinson’s disease, to Cellular Intelligence, an AI biotech […]<br /> This story continues at The Next Web [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
What’s going on with Donut Lab?

In January, a Finnish-Estonian startup proclaimed it had developed a truly solid state battery, a holy grail for the technology industry. Donut Labs’ cell wasn’t just solid state, however. It clai [...]

Match Score: 172.25

Destination
What we’ve learned from FTC v. Meta antitrust trial

Meta is facing its biggest existential threat in its history. Years after the Federal Trade Commission first sued the social network in an attempt to unwind its acquisitions of Instagram and WhatsApp, [...]

Match Score: 116.42

Destination
The wildest details in the Facebook memoir Meta is trying to bury

Sarah Wynn-Williams joined Facebook in 2011 when it was very much in its “move fast and break things” era. A former United Nations diplomat, she had aspirations of helping Facebook boost its stand [...]

Match Score: 100.37

qz
Novo Nordisk is handing its Parkinson's stem cell therapy to a Zuckerberg-backed AI startup

Cellular Intelligence is acquiring STEM-PD, a Phase 2-ready cell therapy, and plans to use AI to accelerate development and manufacturing [...]

Match Score: 96.15

Destination
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump

Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.Read more... [...]

Match Score: 94.32

Destination
Mark Zuckerberg's nonprofit cuts ties with the immigration advocacy group he co-founded

Behold Mark Zuckerberg: man of principle. Witness the Meta CEO's dedication to the most high-minded of causes: "currying favor with whoever's in charge." In 2013, when Barack Obama [...]

Match Score: 84.31

Destination
Mark Zuckerberg and Sheryl Sandberg want you to know they're still friends and definitely not mad at each other

On Thursday, The New York Times published a lengthy story about the rise in power of Stephen Miller, a longtime loyalist of Donald Trump known for his hardline views on immigration. Normally, a story [...]

Match Score: 80.29

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 78.60

Destination
Another big car company gives up on hydrogen

Stellantis, the automotive giant behind Chrysler, Citroen, Fiat, Jeep and Peugeot, is pulling out of hydrogen. The company said it’s killing its fuel cell development program in the face of “limi [...]

Match Score: 69.91